Masaru Takeuchi Selected Research

Masaru Takeuchi Research Topics

Disease

33	Uveitis 09/2023 - 09/2002
29	Inflammation (Inflammations) 09/2023 - 02/2003
12	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 02/2010
9	Sarcoidosis (Schaumann Disease) 01/2020 - 03/2006
7	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 12/2023 - 06/2008
7	Retinal Detachment (Retinal Detachments) 05/2023 - 04/2010
7	Cataract (Cataracts) 01/2022 - 01/2014
7	Macular Edema 01/2022 - 04/2011
7	Acute Retinal Necrosis Syndrome 01/2021 - 09/2002
6	Macular Degeneration (Age-Related Maculopathy) 10/2023 - 09/2014
6	Behcet Syndrome (Behcet's Syndrome) 01/2023 - 10/2006
6	Endophthalmitis (Ophthalmia) 10/2022 - 09/2013
5	Hemorrhage 11/2023 - 11/2005
5	Hypertension (High Blood Pressure) 06/2020 - 05/2009
4	Vitreous Hemorrhage 11/2022 - 01/2017
4	Retinal Perforations 03/2022 - 12/2003
4	Glaucoma 01/2022 - 09/2009
4	Anterior Uveitis 01/2018 - 09/2002
3	Infections 11/2023 - 01/2018
3	Blindness (Hysterical Blindness) 09/2023 - 12/2007
3	Vision Disorders (Hemeralopia) 09/2023 - 04/2020
3	Ocular Hypertension (Glaucoma, Suspect) 01/2020 - 01/2017
3	Neovascular Glaucoma 10/2019 - 01/2018
3	Retinal Vasculitis 07/2017 - 11/2005
3	Delayed Hypersensitivity (Hypersensitivity, Type IV) 08/2004 - 06/2002
2	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 01/2002
2	Ischemia 11/2023 - 01/2018
2	Polypoidal Choroidal Vasculopathy 10/2023 - 03/2023
2	COVID-19 09/2022 - 01/2022
2	Panuveitis 01/2022 - 03/2019
2	Neoplasms (Cancer) 01/2021 - 10/2010
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Retinitis 08/2018 - 06/2013
2	Phototoxic Dermatitis (Phototoxicity) 01/2018 - 10/2012
2	Carcinoma (Carcinomatosis) 12/2017 - 04/2005
2	Retinal Vein Occlusion 01/2017 - 04/2011
2	Phlebitis 01/2017 - 07/2013
2	Iridocyclitis 01/2015 - 11/2005
2	Vitreous Detachment (Posterior Vitreous Detachment) 11/2012 - 04/2010
2	Choroidal Neovascularization 01/2012 - 07/2009
2	Hypersensitivity (Allergy) 04/2009 - 02/2007

Drug/Important Bio-Agent (IBA)

21	Retinaldehyde (Retinal)IBA 11/2023 - 11/2005
17	CytokinesIBA 12/2023 - 01/2006
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 07/2009
13	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2013
8	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2023 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2002
7	AntigensIBA 02/2017 - 06/2002
6	Infliximab (Remicade)FDA Link 01/2023 - 08/2013
6	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2010
5	Fluorescein (Funduscein)FDA LinkGeneric 05/2023 - 01/2012
5	Interleukin-6 (Interleukin 6)IBA 01/2018 - 06/2010
5	SteroidsIBA 02/2017 - 10/2012
5	Interferon-gamma (Interferon, gamma)IBA 09/2014 - 03/2006
4	Adalimumab (Humira)FDA Link 09/2023 - 04/2020
4	InterferonsIBA 01/2021 - 02/2010
4	Interleukin-10 (Interleukin 10)IBA 01/2020 - 10/2010
4	ChemokinesIBA 01/2020 - 02/2003
4	Interleukin-4 (Interleukin 4)IBA 02/2017 - 01/2006
4	Interleukin-8 (Interleukin 8)IBA 10/2011 - 01/2008
4	AutoantigensIBA 06/2010 - 01/2006
3	Coloring Agents (Dyes)IBA 02/2023 - 11/2014
3	AntibodiesIBA 09/2022 - 06/2002
3	Messenger RNA (mRNA)IBA 09/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2020
3	Interleukin-22 (IL-22)IBA 01/2020 - 01/2015
3	Ophthalmic Solutions (Eye Drops)IBA 03/2019 - 01/2015
3	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2019 - 12/2003
3	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 01/2013
3	Latanoprost (Xalatan)FDA Link 07/2017 - 09/2013
3	Tuberculin (PPD)IBA 01/2017 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 06/2013
2	Immunoglobulin G (IgG)IBA 11/2023 - 03/2006
2	EnzymesIBA 11/2022 - 06/2008
2	BNT162 VaccineIBA 09/2022 - 01/2022
2	COVID-19 VaccinesIBA 09/2022 - 01/2022
2	VaccinesIBA 01/2022 - 10/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 04/2020
2	afliberceptIBA 01/2021 - 12/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 01/2014
2	Antiglaucoma AgentsIBA 01/2018 - 01/2017
2	Retinal Pigments (Pigments, Visual)IBA 01/2018 - 10/2012
2	Timolol (Blocadren)FDA LinkGeneric 02/2017 - 09/2013
2	Travoprost (Travatan)FDA Link 02/2017 - 09/2013
2	Ranibizumab (Lucentis)FDA Link 01/2017 - 01/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2011 - 02/2010
2	Peptides (Polypeptides)IBA 04/2009 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 01/2006
1	GlucocorticoidsIBA 12/2023
1	Immunoglobulin M (IgM)IBA 11/2023
1	CryoglobulinsIBA 11/2023

Therapy/Procedure

23	Vitrectomy 11/2023 - 12/2003
19	Therapeutics 12/2023 - 11/2010
5	Aftercare (After-Treatment) 09/2023 - 11/2014
5	Intravitreal Injections 12/2020 - 02/2007
4	Operative Surgical Procedures 06/2020 - 08/2019
4	Light Coagulation 06/2020 - 07/2013
2	Transplantation 08/2022 - 12/2007
2	Slit Lamp 12/2018 - 02/2007
2	Immunotherapy 03/2012 - 04/2009